Target intelligence / Profile preview

Keratin 8 pseudogene 36 (KRT8P36)

Target: KRT8P36
Molecular classification: Other (Pseudogene)

Overview

Keratin 8 pseudogene 36 (KRT8P36) is one of several processed pseudogenes in the human genome derived from the keratin 8 (KRT8) gene, which encodes a type II cytoskeletal protein expressed in simple epithelial cells[3]. KRT8P36 lacks an intact open reading frame and does not produce a functional protein[3]. Pseudogenes like KRT8P36 are generally considered genomic "fossils" and do not participate in structural or regulatory biological functions. As such, they are not considered therapeutic targets and have no known disease associations or relevance for drug interaction, safety, or biomarker use[3]. The principal active gene in this family is KRT8, with numerous related processed pseudogenes distributed throughout the genome[3].

Other names: KRT8P36

Beyond the preview

Go deeper on Keratin 8 pseudogene 36 (KRT8P36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 8 pseudogene 36 (KRT8P36).

Explore the full profile